Skip to content

Clinical trials

Phase 2 Diabetes Mellitus, Type 2 trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 2 Country / region: Netherlands Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20071
20094
20111
20151
20161
20172
20183
20211
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Corcept Therapeutics2
Novartis Pharmaceuticals2
Novo Nordisk A/S2
Akros Pharma Inc.1
Alizyme1
Amgen1
Astellas Pharma Europe B.V.1
AstraZeneca1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 222
Diabetes Mellitus5
Obesity5
Renal Insufficiency, Chronic4
Hypertension3
ACTH Syndrome, Ectopic2
Adrenal Cortex Neoplasms2
Adrenocortical Carcinoma2
Cushing Syndrome2
Heart Failure2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.